<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Monday Morning Update 12/10/07</title>
	<atom:link href="http://histalk2.com/2007/12/09/monday-morning-update-121007/feed/" rel="self" type="application/rss+xml" />
	<link>http://histalk2.com/2007/12/09/monday-morning-update-121007/</link>
	<description>Healthcare IT News and Opinion</description>
	<lastBuildDate>Sun, 20 May 2012 19:02:53 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3</generator>
	<item>
		<title>By: Pierce Bushwhacker</title>
		<link>http://histalk2.com/2007/12/09/monday-morning-update-121007/comment-page-1/#comment-524</link>
		<dc:creator>Pierce Bushwhacker</dc:creator>
		<pubDate>Tue, 11 Dec 2007 17:15:18 +0000</pubDate>
		<guid isPermaLink="false">http://histalk2.com/2007/12/09/monday-morning-update-121007/#comment-524</guid>
		<description>To Warren Treesmiter:

Try sending your Azyxxi RFP request to Peter Markavage [peterma@microsoft.com]</description>
		<content:encoded><![CDATA[<p>To Warren Treesmiter:</p>
<p>Try sending your Azyxxi RFP request to Peter Markavage [peterma@microsoft.com]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Scarlet O'Hara</title>
		<link>http://histalk2.com/2007/12/09/monday-morning-update-121007/comment-page-1/#comment-523</link>
		<dc:creator>Scarlet O'Hara</dc:creator>
		<pubDate>Mon, 10 Dec 2007 15:22:30 +0000</pubDate>
		<guid isPermaLink="false">http://histalk2.com/2007/12/09/monday-morning-update-121007/#comment-523</guid>
		<description>Art Vandelay Correction - Actually HCTSi has two distinct business units, the professional services you rightly named but also products they sell to the health provider market which includes iSirona, a complete point of care data capture solution, www.isirona.com.  They compete with Capsule Technologies rather than resell their product.</description>
		<content:encoded><![CDATA[<p>Art Vandelay Correction &#8211; Actually HCTSi has two distinct business units, the professional services you rightly named but also products they sell to the health provider market which includes iSirona, a complete point of care data capture solution, <a href="http://www.isirona.com" rel="nofollow">http://www.isirona.com</a>.  They compete with Capsule Technologies rather than resell their product.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Datamus</title>
		<link>http://histalk2.com/2007/12/09/monday-morning-update-121007/comment-page-1/#comment-522</link>
		<dc:creator>Datamus</dc:creator>
		<pubDate>Mon, 10 Dec 2007 15:21:14 +0000</pubDate>
		<guid isPermaLink="false">http://histalk2.com/2007/12/09/monday-morning-update-121007/#comment-522</guid>
		<description>I look at this from a patient&#039;s perspective.  While I absolutely want my individual privacy protected, I also want hospitals and providers to study and improve their care.  I want them to know whether their MRSA rates are rising or falling and why.  I want them to understand which doctors have unusually high mortality rates.  All of this requires the pooling of my data with others.  Like anything else, this is a risk.  As someone commented - how do we know de-identification is certain.  

But the question is, am I more concerned about getting a preventable complication or about the use of my de-identified data for quality improvement or even for analysis by pharma companies?  Personally, I am much more concerned about the risks of getting an infection than I am about some pharma company getting my de-identified data, spending money and time trying to re-identify it and then sending me a post card to encourage me to buy more of whatever they sell.  And while I am fairly certain this is not happening, I would still take the risk over dying of a hospital acquired infection or a medication error or whatever.

I wish we could all live a life without risk, but the world doesn&#039;t work that way.  The question is, are we being sensible about the risks that are out there.</description>
		<content:encoded><![CDATA[<p>I look at this from a patient&#8217;s perspective.  While I absolutely want my individual privacy protected, I also want hospitals and providers to study and improve their care.  I want them to know whether their MRSA rates are rising or falling and why.  I want them to understand which doctors have unusually high mortality rates.  All of this requires the pooling of my data with others.  Like anything else, this is a risk.  As someone commented &#8211; how do we know de-identification is certain.  </p>
<p>But the question is, am I more concerned about getting a preventable complication or about the use of my de-identified data for quality improvement or even for analysis by pharma companies?  Personally, I am much more concerned about the risks of getting an infection than I am about some pharma company getting my de-identified data, spending money and time trying to re-identify it and then sending me a post card to encourage me to buy more of whatever they sell.  And while I am fairly certain this is not happening, I would still take the risk over dying of a hospital acquired infection or a medication error or whatever.</p>
<p>I wish we could all live a life without risk, but the world doesn&#8217;t work that way.  The question is, are we being sensible about the risks that are out there.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Dr. M.</title>
		<link>http://histalk2.com/2007/12/09/monday-morning-update-121007/comment-page-1/#comment-521</link>
		<dc:creator>Dr. M.</dc:creator>
		<pubDate>Mon, 10 Dec 2007 15:02:19 +0000</pubDate>
		<guid isPermaLink="false">http://histalk2.com/2007/12/09/monday-morning-update-121007/#comment-521</guid>
		<description>Following up on Art&#039;s response to Jonny Yokel re: HCTSi . . .HCTSi seems to have moved beyond services and has actually manufactured software and hardware to compete with Capsule.  But I wouldn&#039;t add them to anyone&#039;s acquisition list just yet either.  They&#039;re newcomers still working with their alpha customer(s?).  No library of device dll&#039;s to implement.  No reference customers to testify of their success just yet, apart from Clarian, but that was using Capsule&#039;s product and HCTSi&#039;s services.  That&#039;s not to say they won&#039;t be on the radar screen in 5 years, but Capsule&#039;s association as the built-in solution for Epic and Eclipsys device data gives them quite a head-start.</description>
		<content:encoded><![CDATA[<p>Following up on Art&#8217;s response to Jonny Yokel re: HCTSi . . .HCTSi seems to have moved beyond services and has actually manufactured software and hardware to compete with Capsule.  But I wouldn&#8217;t add them to anyone&#8217;s acquisition list just yet either.  They&#8217;re newcomers still working with their alpha customer(s?).  No library of device dll&#8217;s to implement.  No reference customers to testify of their success just yet, apart from Clarian, but that was using Capsule&#8217;s product and HCTSi&#8217;s services.  That&#8217;s not to say they won&#8217;t be on the radar screen in 5 years, but Capsule&#8217;s association as the built-in solution for Epic and Eclipsys device data gives them quite a head-start.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Matthew Holt</title>
		<link>http://histalk2.com/2007/12/09/monday-morning-update-121007/comment-page-1/#comment-520</link>
		<dc:creator>Matthew Holt</dc:creator>
		<pubDate>Mon, 10 Dec 2007 06:20:07 +0000</pubDate>
		<guid isPermaLink="false">http://histalk2.com/2007/12/09/monday-morning-update-121007/#comment-520</guid>
		<description>By the way. The open source guys (esp Fred Trotter) think that Deborah Peel is an unsophisticated neophyte (and that&#039;s the polite interpretation!)</description>
		<content:encoded><![CDATA[<p>By the way. The open source guys (esp Fred Trotter) think that Deborah Peel is an unsophisticated neophyte (and that&#8217;s the polite interpretation!)</p>
]]></content:encoded>
	</item>
</channel>
</rss>

